Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Pfizer touts Tukysa in front-line breast cancer after Phase III victory
Pfizer’s Tukysa (tucatinib) has enhanced patient outcomes when used as a maintenance therapy during a late-stage trial in breast cancer.
Telomir Pharmaceuticals reports new preclinical data on pancreatic cancer
Telomir Pharmaceuticals, Inc., a $54 million market cap biotech company whose stock has declined 11% in the past week
Компания 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study
Gene Therapy Protects Kidneys in Preclinical Model of Type 1 Diabetes
One in three people with type one diabetes will develop kidney damage during their lifetime, which can develop silently over many years, often going undetected until it becomes severe.
FDA grants Fast Track status to Enterome’s EO2463 for follicular lymphoma
Enterome has received fast track designation from the US Food and Drug Administration for its lead OncoMimics immunotherapy EO2463, targeting follicular lymphoma in the low tumour burden ‘watch-and-...
TEVA Gets FDA Nod for Uzedy Label Expansion in Bipolar I Disorder
Teva Pharmaceutical Industries Limited recently announced that the FDA has approved expanded use of its branded product, Uzedy (risperidone).
FDA Breakthrough Designation Signals New Therapeutic Avenue in R/R MCL
The FDA has granted breakthrough therapy designation (BTD) to the investigational B-cell lymphoma 2 (BCL2) inhibitor sonrotoclax (BGB-11417) for the treatment of adult patients...
Preclinical study identifies genetic misfire in lupus
Cedars-Sinai investigators have identified a "molecular switch" on a gene strongly associated with the autoimmune disease lupus, which appears to propel immune cells into overdrive, attackin...
Tvardi Therapeutics’ stock crashes on Phase II IPF flop
Tvardi Therapeutics’ stock has crashed more than 80% after the company revealed that its idiopathic pulmonary fibrosis (IPF) candidate flunked in a Phase II trial.
Preclinical study finds antidepressant may boost SMN
A preclinical study found that blocking the SMPD1 enzyme with available drugs such as the antidepressant clomipramine increases the levels of SMN
FDA Approves At-Home Lasix for Heart Failure
The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by...
Lupin's New Jersey Facility Passes FDA
Lupin's New Jersey Facility Passes FDA Inspection; Plans $250M Investment in Florida
45
46
47
48
49
50
51
52
53
